Hot Features
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive ... Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.25 | -15.0421179302 | 8.31 | 8.64 | 7.04 | 616292 | 7.71245162 | CS |
| 4 | -1.82 | -20.4954954955 | 8.88 | 9.595 | 7.04 | 597970 | 8.40881565 | CS |
| 12 | -2.26 | -24.2489270386 | 9.32 | 10.6676 | 7.04 | 601585 | 9.09172903 | CS |
| 26 | -20.76 | -74.622573688 | 27.82 | 33.68 | 7.04 | 898450 | 14.15191213 | CS |
| 52 | -3.79 | -34.930875576 | 10.85 | 33.68 | 7.04 | 681263 | 15.43897687 | CS |
| 156 | -14.44 | -67.1627906977 | 21.5 | 33.68 | 5.14 | 539870 | 15.07852755 | CS |
| 260 | -14.44 | -67.1627906977 | 21.5 | 33.68 | 5.14 | 539870 | 15.07852755 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.